Zika virus and the never-ending story of emerging pathogens and transfusion medicine
- PMID: 26674815
- PMCID: PMC4786129
- DOI: 10.2450/2015.0066-15
Zika virus and the never-ending story of emerging pathogens and transfusion medicine
Abstract
In the last few years, the transfusion medicine community has been paying special attention to emerging vector-borne diseases transmitted by arboviruses. Zika virus is the latest of these pathogens and is responsible for major outbreaks in Africa, Asia and, more recently, in previously infection-naïve territories of the Pacific area. Many issues regarding this emerging pathogen remain unclear and require further investigation. National health authorities have adopted different prevention strategies. The aim of this review article is to discuss the currently available, though limited, information and the potential impact of this virus on transfusion medicine.
Figures
Comment in
-
Blood safety and zoonotic emerging pathogens: now it's the turn of Zika virus!Blood Transfus. 2016 Mar;14(2):93-4. doi: 10.2450/2015.0187-15. Epub 2015 Nov 5. Blood Transfus. 2016. PMID: 26674809 Free PMC article. No abstract available.
-
Zika virus: new emergencies, potential for severe complications, and prevention of transfusion-transmitted Zika fever in the context of co-circulation of arboviruses.Blood Transfus. 2017 May;15(3):272-273. doi: 10.2450/2016.0003-16. Epub 2016 Apr 28. Blood Transfus. 2017. PMID: 27177409 Free PMC article. No abstract available.
References
-
- de Mendoza C, Altisent C, Aznar JA, et al. Emerging viral infections: a potential threat for blood supply in the 21st century. AIDS Rev. 2012;14:279–89. - PubMed
-
- Paty MC. The expansion of vector-borne diseases and the implications for blood transfusion safety: the case of West Nile virus, dengue and chikungunya. Transfus Clin Biol. 2013;20:165–73. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical